DNA’s year 2018 off to a strong start – record-high mobile service revenue

Summary

Unless otherwise stated, the comparison figures in brackets refer to the corresponding period in the previous year (reference period). Figures are unaudited.

For 2018, as required by the IFRS standards, the financial tables contain figures reported according to the IFRS 15 and IFRS 9 standards adopted on 1 January 2018 and, as required by IFRS 15, figures adjusted are disclosed as if they were prepared under 2017 revenue guidance. The comparative analysis in the report section is disclosed as if the figures were prepared under 2017 revenue guidance. More information: Note 11. 

January–March 2018

  • Net sales increased 4.2% and amounted to EUR 222.3 million (213.4 million).
  • EBITDA increased 9.6% to EUR 72.3 million (65.9 million), or 32.5% (30.9%) of net sales.
  • There were no items affecting the comparability of EBTIDA or operating result in the review or reference period.
  • Operating result increased 23.3% and was EUR 35.6 million (28.9 million). Operating result as a percentage of net sales was 16.0% (13.5%).
  • Operating free cash flow grew 14.7% to EUR 56.4 million (49.2 million).
  • Earnings per share increased and was EUR 0.19 (0.16).
  • The mobile communication subscription base grew 2.9%, totalling 2,811,000 (2,732,000).
  • Revenue per user (ARPU) for mobile communications amounted to EUR 19.0 (17.8).
  • The mobile communication subscription turnover rate (CHURN) was 18.9% (21.0%).
  • The fixed-network subscription base (voice, broadband and cable television) had 1,138,000 subscriptions (1,120,000).

DNA’s guidance for 2018 remains unchanged

DNA’s net sales and comparable operating result are expected in 2018 to remain at the same level as in 2017. The Group’s financial position and liquidity is expected to remain at a healthy level.

DNA's guidance for 2018 is disclosed as it was prepared under 2017 revenue guidance and does not currently incorporate the potential impact from the adoption of IFRS 15 as of 1 January 2018. 


Key figures


Figures are unaudited.








EUR million 1-3/2018 Reported 1-3/2018 Adjusted* 1-3/2017 Reported Change -% 1-12/2017 Reported
Net sales 222.3 222.3 213.4 4.2% 886.1
EBITDA 70.7 72.3 65.9 9.6% 271.8
- % of net sales 31.8% 32.5% 30.9%
30.7%
Comparable EBITDA ** 70.7 72.3 65.9 9.6% 271.8
- % of net sales 31.8% 32.5% 30.9%
30.7%
Depreciation, amortisation and impairment 35.4 36.7 37.1
148.2
Operating result, EBIT 35.2 35.6 28.9 23.3% 123.5
- % of net sales 15.8% 16.0% 13.5%
13.9%
Comparable operating result** 35.2 35.6 28.9 23.3% 126.6
- % of net sales 15.8% 16.0% 13.5%
14.3%
Net result before tax 30.6 31.0 26.6 16.3% 114.2
Net result for the period 24.4 24.7 21.2 16.6% 93.1
Return on investment (ROI), % 14.4 15.2 12.5
13.1
Return on equity (ROE), % 16.7 18.2 14.9
15.5
Capital expenditure 19.9 20.3 21.2 -4.3% 144.0
Cash flow after investing activities -7.9 -7.9 10.3
107.7
Free cash flow to equity -3.5 -3.5 14.7
118.8
Net debt 304.0 304.0 314.3
304.3
Net debt/EBITDA 1.08 1.05 1.19
1.12
Net gearing, % 57.9 62.9 57.6
50.3
Equity ratio, % 38.8 37.2 45.3
50.6
Basic earnings per share, EUR 0.19 0.19 0.16
0.71
Diluted earnings per share, EUR 0.19 0.19 0.16
0.71
Personnel at the end of period 1,599 1,599 1,684
1,601
*Adjusted figures are disclosed as prepared under 2017 revenue guidance and do not currently incorporate the impact from the adoption of IFRS 15 as of 1 January 2018.
**Group key figures

Additional information:

Jukka Leinonen, CEO, DNA Plc, +358 44 044 1000, jukka.leinonen(at)dna.fi
Timo Karppinen, CFO, DNA Plc, +358 44 044 5007, timo.karppinen(at)dna.fi
Marja Mäkinen, Head of IR, DNA Plc, +358 44 044 1262, marja.makinen(at)dna.fi
DNA Corporate Communications, +358 44 044 8000, viestinta(at)dna.fi

DNA’s financial publications in 2018:

  • 19 July 2018: Half Year Financial Report 1–6/2018
  • 19 October 2018: Interim Report 1–9/2018